dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Fivefold difference found in Medicaid reimbursements for radiotherapy May limit access to healthcare, especially in rural areas

Trends in radiation oncology workforce potentially threaten rural patients, says study More radiation oncologists leaving, fewer coming in to rural areas

Varian showcases first preclinical findings of Flash therapy trial Reductions in radiation lung fibrosis and dermatitis

Female oncologists submit fewer charges, paid less than male Study bases findings on Medicare records

Four considerations before embarking on a carbon therapy center The next frontier in improving cancer care

New approach identifies lung cancer patients most likely to respond to chemotherapy Combines radiomics and CT image assessment

Q&A with Scott Warwick, executive director of the National Association for Proton Therapy Find out what to expect at the year's biggest proton therapy industry event

Aussies and Americans develop 3D models for assessing impacts of radiotherapy Test different levels and types of radiation

Law in Ontario prevents cremation of brachytherapy patients Experts call for eliminating the law, as it deters patients from lifesaving treatment

IBA tech plays first-time role in flash therapy demonstration Supports eventual integration of flash as clinical treatment

The Maryland Proton Treatment Center is
the first to offer both hyperthermia and
proton therapy in the same facility

Maryland Proton Treatment Center combines hyperthermia with proton therapy

by John R. Fischer , Staff Reporter
The Maryland Proton Treatment Center (MPTC) has become the first in the world to bring the benefits of deep-tissue external thermal therapy (hyperthermia) to high-precision proton therapy.

Looking to boost survival chances for patients, the Baltimore-based facility plans to administer hyperthermia in combination with proton therapy for treating difficult to reach cancers in the abdomen and pelvic region, based on supporting evidence and studies that suggest the addition of heat sensitizes tumors to radiotherapy and chemotherapy, allowing both to significantly reduce the size of tumors.

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs



“We can offer this treatment to patients, in particular the ones that previously failed at radiation and have to be re-radiated again. In those cases, you are limited in how much radiation can be delivered because of the risk of damage to surrounding organs. That’s why protons are extremely useful," Zeljko Vujaskovic, a professor of radiation oncology and director of the division of translational radiation sciences (DTRS) in the department of radiation oncology at the University of Maryland School of Medicine (UMSOM), told HCB News. "Protons minimize the radiation spillover to critical structures and healthy tissue. If you combine with heat, you can really get more out of this limited dose of radiation that you are trying to deliver a second time."

With a range of 104° F to 110° F, hyperthermia has been proven to sensitize tumor cells to radiotherapy and chemotherapy, as well as enhance anti-tumor immune response. Though applied by radiation oncologists to treat a range of cancers at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC), their use of hyperthermia has not extended to cancers deep in the body.

Using deep-tissue thermal therapy equipment made by Pyrexar, clinicians at MPTC will raise the temperature of the tissue of tumors to 108° F, distributing the heat with internal and external probes that enable continuous temperature monitoring. A water-filled applicator will be put in place over the area that requires treatment, directing non-invasive radio frequency energy at the tumor, with the heat dilating blood vessels and bringing more oxygen into the mass, which makes the cancer cells more vulnerable to radiation therapy.

The application of thermal therapy is a time-consuming, laser intensive treatment with a relatively modest reimbursement that makes it difficult for some facilities to incorporate it. It also requires expertise and training, making it even less widespread, especially outside academic hospitals.
  Pages: 1 - 2 >>

Rad Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED